Astaxanthin Attenuates Nonalcoholic Steatohepatitis with Downregulation of Osteoprotegerin in Ovariectomized Mice Fed Choline-Deficient High-Fat Diet-Reference-Cited by-同舟云学术

Astaxanthin Attenuates Nonalcoholic Steatohepatitis with Downregulation of Osteoprotegerin in Ovariectomized Mice Fed Choline-Deficient High-Fat Diet

Published:2022-04-10 Issue:1 Volume:68 Page:155-163
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Zhao Meng,Ma Lingyun,Honda Takashi^ORCID,Kato Asuka,Ohshiro Taichi,Yokoyama Shinya,Yamamoto Kenta,Ito Takanori,Imai Norihiro,Ishizu Yoji,Nakamura Masanao,Kawashima Hiroki,Tsuji Noriko M.,Ishigami Masatoshi,Fujishiro Mitsuhiro

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10620-022-07489-6.pdf

Reference45 articles.

1. Lonardo A, Nascimbeni F, Ballestri S et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology 2019;70:1457–1469. https://doi.org/10.1002/hep.30626.

2. Lee C, Kim J, Jung Y. Potential therapeutic application of estrogen in gender disparity of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Cells. 2019. https://doi.org/10.3390/cells8101259.

3. Zhou Y, Shimizu I, Lu G et al. Hepatic stellate cells contain the functional estrogen receptor β but not the estrogen receptor α in male and female rats. Biochem Biophys Res Commun 2001;286:1059–1065. https://doi.org/10.1006/bbrc.2001.5479.

4. Arshad T, Golabi P, Paik J et al. Prevalence of nonalcoholic fatty liver disease in the female population. Hepatol Commun 2019;3:74–83. https://doi.org/10.1002/hep4.1285.

5. Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med 2018;24:908–922. https://doi.org/10.1038/s41591-018-0104-9.